From October 1, 2023 to March 31, 2024, the company has repurchased 35,851,329 shares, representing 4.74% for CNY 222.07 million. With this, the company has completed the repurchase of 49,999,929 shares, representing 6.59% for CNY 322.09 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 CNY | +0.64% | -3.66% | -8.41% |
1st Jan change | Capi. | |
---|---|---|
-8.41% | 628M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.